FP7
DDMORE
Drug Disease Model Resources
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 23,063,274
- EU contribution
- EUR 10,399,426
- Participants
- 24 from 11 countries
- Topic
- FP7_IMI-JU-02-2009-07
- Grant agreement
- 115156
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Interface Europe | BEBelgium | Participant | EUR 477,891 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| Takeda Pharmaceuticals International AG | CHSwitzerland | Participant | Not stated | PIC (1.00) |
| European Molecular Biology Laboratory | DEGermany | Participant | EUR 1,391,410 | PIC (1.00) |
| Freie Universitaet Berlin | DEGermany | Participant | EUR 369,910 | known name (0.95) |
| Martin-Luther-Universitat Halle-Wittenberg | DEGermany | Participant | EUR 1,182 | known name (0.95) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | Not stated | PIC (1.00) |
| Novo Nordisk A/S | DKDenmark | Participant | Not stated | PIC (1.00) |
| Universidad de Navarra | ESSpain | Participant | EUR 189,312 | PIC (1.00) |
| Institut de Recherches Internationales Servier | FRFrance | Participant | Not stated | PIC (1.00) |
| Institut National de Recherche en Informatique et Automatique | FRFrance | Participant | EUR 570,533 | PIC (1.00) |
| Lixoft Sas | FRFrance | Participant | EUR 270,753 | PIC (1.00) |
| Université Paris Diderot-Paris 7 | FRFrance | Participant | EUR 308,651 | PIC (1.00) |
| Certara UK Limited | GBUnited Kingdom | Participant | EUR 145,000 | PIC (1.00) |
| Cyprotex Discovery Limited | GBUnited Kingdom | Participant | EUR 333,357 | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | Not stated | PIC (1.00) |
| Mango Business Solutions Limited | GBUnited Kingdom | Participant | EUR 1,794,522 | PIC (1.00) |
| University College London | GBUnited Kingdom | Participant | EUR 189,560 | known name (0.95) |
| Optimata Ltd | ILIsrael | Participant | EUR 147,278 | PIC (1.00) |
| Universita Degli Studi di Pavia | ITItaly | Participant | EUR 942,620 | known name (0.95) |
| Universiteit Leiden | NLNetherlands | Participant | EUR 1,103,588 | known name (0.95) |
| Astrazeneca AB | SESweden | Participant | Not stated | PIC (1.00) |
| Uppsala Universitet | SESweden | Participant | EUR 1,805,231 | known name (0.95) |
Changes of the consortium
First seen on with 24 participants from 11 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.